Accentus Medical is a leading medical technology company that combines over 30 years of expertise in surface coating and modification technologies with dedicated research and development of new technologies for the medical device industry. Accentus Medical’s Acusure® range is designed to improve both biocompatibility and/or durability of orthopaedic and certain other implantable medical devices. The range includes a series of advanced hydroxyapatite and particulate metal coatings that are produced using proprietary inert/reducing gas, thermal plasma spraying techniques. Acusure® coatings have been in worldwide clinical usage for over 12 years. Agluna® is Accentus Medical’s novel surface modification technology applied during the manufacture of medical devices to effectively prevent deep-seated infection. Supported by a strong patent portfolio, the technology is being applied to titanium alloy surgical orthopaedic implants and is currently being supplied to licensee Stanmore Implants Worldwide Ltd on custom made limb salvage implants and patient specific joint replacements. Furthermore, the application of Agluna® in many other medical devices is being evaluated, Joint Reconstruction, Traumatology, Spinal surgery, Dentistry, Cardiology and Neurology for example.
View Top Employees from ACCENTUS LTDWebsite | http://www.accentus-medical.com |
Revenue | $8 million |
Employees | 3 (2 on RocketReach) |
Founded | 2001 |
Phone | +44 1235 434320 |
Fax | +44 1235 434329 |
Industry | Retail, Business Consulting and Services |
Competitors | ENBIO Ltd, Keronite, N2 Biomedical, Oxford Advanced Surfaces Group plc, WEMEC Ltd |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular ACCENTUS LTD employee's phone or email?
The ACCENTUS LTD annual revenue was $8 million in 2024.
2 people are employed at ACCENTUS LTD.
The NAICS codes for ACCENTUS LTD are [33, 339].
The SIC codes for ACCENTUS LTD are [38, 384].